Stroke/Cerebrovascular Disease Perspective

• Five New Neurology Studies: Possible Breakthroughs, Some Failures   Dr Christoph Diener on promising early results in muscular dystrophy and Creutzfeldt-Jakob disease, and discouraging ones for aducanumab.
  Medscape Neurology, May 09, 2022
• Diabetes & Kidney Disease: A Heart in Jeopardy: Helping a Hero   An Air Force veteran with CKD shares his experience managing multiple chronic conditions and participating in research trials.
  Medscape TV, May 09, 2022
• Aspirin in Primary Prevention of CVD: Rational Use   The aspirin question returns as the balance of benefits vs harms for some patient groups is reassessed.
  Medscape Ob/Gyn, May 04, 2022
• ESOC 2022 Read clinically focused news coverage of key developments from ESOC 2022
  Medscape Neurology, May 04, 2022
• Gastroenterologists Can Do Better at Managing Antithrombotics   We need to be more mindful of stopping anticoagulants/antiplatelets during acute GI bleeds and endoscopy, says Dr David Johnson.
  Medscape Gastroenterology, April 14, 2022
• Eric Topol: 'I Still Have My Guard Up'   Why we should be shifting into high gear on treatments for long COVID and a pan-beta-coronavirus vaccine.
  Medscape, April 08, 2022
• Recent Findings in Neurology: Multiple Sclerosis and Stroke   Dr Christoph Diener discusses recent studies in neurology focused on multiple sclerosis and stroke.
  Medscape Neurology, April 06, 2022
• ACC 2022 Percutaneous Left Atrial Appendage Occlusion: Promise vs Reality The selling point of percutaneous left atrial appendage occlusion is to prevent stroke while avoiding the bleeding risk of antithrombotics. The data paint a different picture, writes John Mandrola, MD.
  theheart.org on Medscape, April 04, 2022
• ACC 2022 Mandrola Previews ACC 2022 Studies on sodium restriction, fractional flow reserve, and strategies to improve patient and clinician behavior intrigue, but the best part of ACC22 is that it's largely in-person, writes John Mandrola, MD.
  theheart.org on Medscape, March 29, 2022
• Mar 25 2022 This Week in Cardiology   AF ablation vs rate control in HF, TAVI vs SAVR, atherosclerosis, and surrogate endpoints in observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, March 25, 2022
• Episode 2: A Brave New World in Type 2 Diabetes Treatment and Beyond   Where are the biggest cardiovascular benefits for your patients with type 2 diabetes? Host Silvio Inzucchi and cardiologist Mikhail Kosiborod reveal winning strategies -- for managing much more than just type 2 diabetes.
  Medscape, March 22, 2022
• Episode 1: High-Impact Type 2 Diabetes Treatment Guidelines   Huge improvements in treatments for type 2 diabetes are outlined in recent diabetes guidelines. Get the upshot on best evidence from leading experts Drs Silvio Inzucchi and Rita Kalyani.
  Medscape, March 22, 2022
• COVID-19 and the Heart: Is Cardiology Ready?   Robert Harrington, MD, interviews Ziyad Al-Aly, MD, about his recent paper in Nature Medicine focused on the long-term cardiovascular effects of COVID-19.
  theheart.org on Medscape, March 14, 2022
• Mar 11 2022 This Week in Cardiology   AF screening, CTA, stroke prevention and broken observational studies, and medical writing are the topics John Mandrola, MD discusses in this week’s podcast.
  theheart.org on Medscape, March 11, 2022
• Post–COVID-19 Headache and Migraine: What's the Connection?   Dr Deena Kuruvilla discusses the relationship between post–COVID-19 headache and migraine.
  American Headache Society and Medscape, March 11, 2022
• Antiseizure Meds and Cardiovascular Risk   Dr Andrew Wilner speaks with researcher Dr Colin Josephson about how big data is revealing the ways that certain epilepsy treatments elevate risks.
  Medscape Neurology, February 28, 2022
• What Is the Healthiest Salt for You? Are low-salt, no-salt, and sea salt better for your health than table salt? That might just depend on you.
  Medscape Nephrology, February 28, 2022
• What Are the Determinants of Cardiovascular Disease Risk Equivalents Among Adults with Diabetes Mellitus? For patients with diabetes without prior CVD, there is higher associated relative CVD risk among women, patients of younger age, White race, elevated CRP or triglyceride levels, or decreased kidney function.
  ACC.org, February 23, 2022
• Episode 6: Recent Clinical Advances in Reducing Risk for Dyslipidemia   Our expert trio outlines which of the newer dyslipidemia therapies to prioritize and how to address common obstacles to incorporating them into patient care.
  Medscape, February 15, 2022
• Diabetes & Kidney Disease: A Heart in Jeopardy: When Persistence Pays Off   After decades of failed trials, experts explain the significance of the arrival of inhibitors and nonsteroidal mineralocorticoid receptor antagonists for patients with CKD.
  Medscape TV, February 09, 2022